|
immaterial entity
|
BFO_0000141 |
|
|
independent continuant
|
BFO_0000004 |
|
|
temporal region
|
BFO_0000008 |
|
|
two-dimensional spatial region
|
BFO_0000009 |
|
|
Test Facility Name
|
NCIT_C90469 |
|
|
NCIT_C90468
|
NCIT_C90468 |
|
|
Test Facility Country
|
NCIT_C90467 |
|
|
directive information entity
|
IAO_0000033 |
|
|
Thai clinical trials registry
|
CTO_0000050 |
|
|
Cuban public registry of clinical trials identifier
|
CTO_0000055 |
|
|
jRCT clinical trial identifier
|
CTO_0000054 |
|
|
Japan clinical trial identifier
|
CTO_0000209 |
|
|
Brazilian clinical trials registry
|
CTO_0000053 |
|
|
Indian clinical trial registry identifier
|
CTO_0000052 |
|
|
Thai clinical trials registry identifier
|
CTO_0000048 |
|
|
prospective study design
|
CTO_0000047 |
|
|
clinical trial phase 1/2
|
CTO_0000046 |
|
|
International standard randomised controlled trial register identifier
|
CTO_0000045 |
|
|
Intervention Type
|
NCIT_C98747 |
|
|
Chinese clinical trial registry
|
CTO_0000049 |
|
